About This Calculator

This companion guide provides clinical context for the Treprostinil Infusion Calculator (ng/kg/min). Treprostinil is a potent pulmonary and systemic vasodilator used to treat pulmonary arterial hypertension (PAH). Due to its narrow therapeutic index and administration via continuous infusion, dosing calculations must be precise. This information supports healthcare professionals in understanding the inputs, outputs, and clinical considerations related to the calculator. It is not a substitute for clinical judgment or institutional protocols.

Understanding the Calculator Outputs

The tool provides several key values based on your inputs, essential for safe medication administration:

• Infusion Rate (mL/hr): When you input a desired dose, the calculator determines the pump rate required to deliver it based on the patient's weight and drug concentration.
• Calculated Dose (ng/kg/min): If you know the infusion rate, the tool calculates the precise weight-based dose the patient is receiving. This is vital for verifying current dosing or during patient handovers.
• Total Daily Dose & Volume: These outputs help in planning medication supply, monitoring fluid balance, and anticipating cassette or syringe changes.
• Titration Helper: This feature simplifies dose adjustments by calculating the new infusion rate required to achieve a new target dose (e.g., increasing by 2 ng/kg/min).

How to Use the Calculator

Follow these steps for an accurate calculation:

• 1. Select Calculation Mode: Choose whether you need to find the "Infusion Rate" from a known dose or calculate the "Dose" from a known rate.
• 2. Enter Patient Weight: Input the patient's weight and select the correct unit (kg or lbs). The calculator converts lbs to kg for the formula.
• 3. Input Dose or Rate: Enter the known variable (either the desired dose in ng/kg/min or the current infusion rate in mL/hr).
• 4. Specify Drug Concentration: Select the concentration of the treprostinil solution. You can choose a standard vial concentration (e.g., 1 mg/mL, 2.5 mg/mL) or use the "Custom Dilution" mode by entering the total drug amount (mg) and total solution volume (mL).
• 5. Use Titration Helper (Optional): If making a dose change, enable the titration helper, input the current dose, and the desired dose change (e.g., '2' to increase, '-2' to decrease).

Dosing Overview

Treprostinil dosing is highly individualized and must be managed by a clinician experienced in treating PAH. General principles include:

• Initial Dosing: A common starting dose for continuous parenteral infusion is 1.25 ng/kg/min. Depending on clinical urgency and setting, some protocols may start at 2.5 ng/kg/min.
• Titration: The dose is cautiously increased based on clinical response (symptom improvement, hemodynamics) and tolerability (side effects). Typical titration steps are 1.25 to 2.5 ng/kg/min at intervals of 24-72 hours or longer.
• Maintenance Dosing: The long-term dose varies significantly among patients, often reaching levels much higher than the initial dose. There is no single target maintenance dose.

Switching and Transitions

Transitioning a patient to or from treprostinil requires extreme care. This includes switching from other prostanoids (e.g., intravenous epoprostenol) or between different formulations of treprostinil. These transitions must be performed in a monitored setting, typically involving overlapping the infusions and titrating one up while the other is weaned down, according to established institutional protocols.

Missed Dose or Infusion Interruption

Due to its short half-life (approximately 4 hours), abrupt withdrawal or a sudden large reduction in treprostinil dose can lead to rebound pulmonary hypertension, causing symptoms like dizziness, dyspnea, and weakness, and can be life-threatening. Patients and caregivers must be educated on the importance of maintaining continuous infusion and having backup pumps and infusion supplies readily available.

Safety Alerts

Treprostinil is a high-alert medication. All calculations, pump programming, and line changes must be independently double-checked by a second qualified healthcare professional before administration.

• Infusion Site Reactions: Pain and erythema at the infusion site are very common with subcutaneous administration.
• Catheter-Related Infections: Patients with central venous catheters for intravenous administration are at high risk for bloodstream infections. Strict aseptic technique is mandatory.
• Vasodilatory Effects: Side effects such as headache, flushing, jaw pain, diarrhea, and hypotension are common, especially during dose initiation and titration.

Frequently Asked Questions (FAQ)

• Why is treprostinil dosed in nanograms (ng)?
  Treprostinil is extremely potent, so it is dosed in very small quantities. Using nanograms allows for precise, manageable numbers in clinical practice. 1,000,000 nanograms (ng) = 1 milligram (mg).
• How do I use the "Custom Dilution" feature?
  Select "Custom Dilution" and enter the total amount of drug (in mg) and the total volume of the final solution (in mL). The calculator will determine the resulting concentration in mg/mL to use in its formula.
• Can this calculator be used for inhaled or oral treprostinil?
  No. This tool is designed exclusively for continuous subcutaneous or intravenous treprostinil infusion calculations. Dosing for other formulations (e.g., Tyvaso®, Orenitram®) is completely different.
• What does the titration helper do?
  It streamlines dose changes. After calculating the initial rate or dose, you can input that dose into the "Current Dose" field and then enter the desired change (e.g., "2.5") in the "Titration Step" field. It instantly shows the new target dose and the corresponding new infusion rate.
• What if the calculated rate or dose seems incorrect or unusually high?
  Immediately stop and re-verify all inputs: patient weight, weight unit (kg vs. lbs), dose, and especially the drug concentration. A misplaced decimal point in the concentration can lead to a ten-fold dosing error.
• Why is a double-check so critical?
  As a high-alert medication, errors with treprostinil can have severe, rapid-onset consequences, including profound hypotension or life-threatening rebound pulmonary hypertension. An independent double-check is a crucial safety barrier.
• Does the calculator store any patient information?
  No. The calculator operates entirely within your browser. No data is saved or transmitted. Refreshing the page will clear all fields.
• What concentration should I use if I am adding treprostinil to a larger bag of fluid?
  Use the "Custom Dilution" mode. For example, if you add 20 mg of treprostinil to a 100 mL bag of sterile diluent, you would enter "20" for the drug amount and "100" for the solution volume.

References

• Remodulin® (treprostinil) Injection Prescribing Information. U.S. Food and Drug Administration (FDA). View FDA Label
• United Therapeutics Corporation. Remodulin® for Healthcare Professionals. Visit Manufacturer Website
• Kitterman, N., Poms, A., Miller, M., & Chakinala, M. (2020). A Practical Guide to Parenteral Prostacyclin Therapy in Patients with Pulmonary Arterial Hypertension. Advances in Pulmonary Hypertension, 19(2), 58-67. View Article
• Galiè, N., Humbert, M., Vachiery, J. L., et al. (2016). 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension. European Heart Journal, 37(1), 67-119. View Guidelines